Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Overgaard

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Theoretical Biology|June 25, 2005
Insights to the minimal model of insulin secretion through a mean-field beta cell modelR V Overgaard, J E Henriksen, H Madsen
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2015
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug DevelopmentR V Overgaard, S H Ingwersen, C W Tornøe
Diabetes, Obesity & Metabolism|February 3, 2016
Exposure-response analyses of liraglutide 3.0 mg for weight managementJ P H Wilding, R V Overgaard, L V Jacobsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 1, 2013
Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic TreatmentsJ B Møller, R V Overgaard, M C Kjellsson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Theoretical Biology|June 25, 2005
Insights to the minimal model of insulin secretion through a mean-field beta cell modelR V Overgaard, J E Henriksen, H Madsen
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2015
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug DevelopmentR V Overgaard, S H Ingwersen, C W Tornøe
Diabetes, Obesity & Metabolism|February 3, 2016
Exposure-response analyses of liraglutide 3.0 mg for weight managementJ P H Wilding, R V Overgaard, L V Jacobsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 1, 2013
Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic TreatmentsJ B Møller, R V Overgaard, M C Kjellsson, et al.
Pageof 1